[1]
2026. Machine Learning-Based Radiomic Signatures for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer. Journal of Cancer Research Updates. 15, 4 (Oct. 2026), 360–370. DOI:https://doi.org/10.30683/1929-2279.2026.15.32.